BREAKINGتازہ ترینताज़ा खबर
Ecuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in Upset
Advertisement
Text size:
USA • 2026-11-07, 10:18 ET • ~1 min read

Two promising heart drugs fail in major trials, dashing cardiologists' hopes

Two promising heart drugs fail in major trials, dashing cardiologists' hopes

Two promising heart drugs fail in major trials, dashing cardiologists' hopes

Two promising heart drugs fail in major trials, dashing cardiologists' hopes

Key points

اہم نکات

मुख्य बातें

  • Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports.
  • Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine.
  • Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events.
  • Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports.
  • Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine.
  • Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events.
  • Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports.
  • Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine.
  • Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events.

Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports. Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine. Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events. Experts called the double setback a huge blow, though other Lp(a) drugs from Amgen and Eli Lilly are still in trials.

Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports. Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine. Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events. Experts called the double setback a huge blow, though other Lp(a) drugs from Amgen and Eli Lilly are still in trials.

Two heart drugs that cardiologists had high hopes for have both failed in large clinical trials, The New York Times reports. Novartis's pelacarsen cut levels of the fatty particle Lp(a) by about 80% in more than 8,300 patients, but it did not prevent heart attacks, strokes or heart-related deaths, with full results presented at the American Heart Association meeting in Chicago and published in the New England Journal of Medicine. Novo Nordisk's ziltivekimab also hit its target, lowering inflammation in 6,300 high-risk patients, yet failed to prevent major heart events. Experts called the double setback a huge blow, though other Lp(a) drugs from Amgen and Eli Lilly are still in trials.

Most read

سب سے زیادہ پڑھی گئی

सबसे ज़्यादा पढ़ी गई

  1. Loading...
Advertisement